Allogeneic Cell Therapy - Global Market Insights and
Dublin, Aug. 22, 2023 (GLOBE NEWSWIRE) -- The "Global Allogeneic Cell Therapy Market: Distribution by Type of Cell Therapy, Source of Cell, Target...
Source: globenewswire.com
📰 Terapia Celular News
Terapia Celular News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Terapia Celular. Real-time updates on events, politics, business and more.
Global Allogeneic Cell Therapy Market Report 2023-2035: Celularity, Allogene Therapeutics, and Fate Therapeutics Driving Innovation, Heralding a New Era in Regenerative Medicine
/PRNewswire/ -- The "Allogeneic Cell Therapy: Global Market Report 2023-2035" report has been added to ResearchAndMarkets.coms offering. The global allogeneic...
United Kingdom United States Stanford University Nordrhein Westfalen New South Wales Soochow University
Source: prnewswire.com
DelveInsight Business Research, LLP: Extremely Robust COVID-19 Clinical Trial Pipeline With 420+ Key Companies Expected to Change the Pace of the COVID-19 Treatment
COVID-19 clinical trial pipeline constitutes 420+ key companies continuously working towards developing 520+ COVID-19 vaccines and drugs, analyzes DelveInsight LAS VEGAS, Nov. 8, 2022 /PRNewswire/
Kan Jang United States United Kingdom Westvac Biopharma Globavir Biosciences Lifefactors Zona Franca
Source: finanznachrichten.de
Feb 5, 2021 | California Newswire
Feb 5, 2021 AUSTIN, Texas, Feb. 5, 2021 (SEND2PRESS NEWSWIRE) -- Kalyagen™, along with the Sociedad Espanola de Medicina Regenerativa y Terapia Celular (the "Spanish Society of Regenerative Medicine and Cell Therapy"), is pleased to announce the launch of a multicenter clinical trial, "The Effect of Stemregen and Adipose Stroma Vascular Fraction (SVF) Either Individually or in Combination in Patient With Heart Failure," to evaluate the use of stem cell therapies in patients suffering from hea...
United States Sociedad Espanola De Medicina Regenerativa Terapia Celular Regenerative Medicine Adipose Stroma Vascular Fraction Either Individually
Source: californianewswire.com
Kalyagen Announces Clinical Trial Launch to Evaluate STEMREGEN and Stem Cells for Advanced Heart Failure Patients
(AUSTIN, Texas) — NEWS: Kalyagen™, along with the Sociedad Espanola de Medicina Regenerativa y Terapia Celular (the “Spanish Society of Regenerative Medicine and Cell Therapy”), is pleased to announce the launch of a multicenter clinical trial, “The Effect of Stemregen and Adipose Stroma Vascular Fraction (SVF) Either Individually or in Combination in Patient With Heart Failure,” to evaluate the use of stem cell therapies in patients suffering from heart failure. STEMREGEN® is a na...
United States Christian Drapeau Herbert Dogan Miguel Garber Spanish Society Of Regenerative Medicine Drug Administration
Source: enewschannels.com